Study of Airflow in the Lungs Using Helium MRI



Status:Recruiting
Conditions:Bronchitis, Chronic Obstructive Pulmonary Disease, Healthy Studies
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:10/21/2017
Start Date:November 2013
End Date:July 2018
Contact:Rachel Dieterich, RN
Email:rrd8w@virginia.edu
Phone:434-243-6074

Use our guide to learn which trials are right for you!

Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI

Computer simulations are being developed to predict air flow abnormalities in the airways of
patients with lung disease. The purpose of this study is to obtain actual gas flow
measurements in the lungs of healthy patients and patients with lung disease and use these
measurements to validate the computer models.

The Biotechnology High Performance Computing Software Applications Institute (BHSAI) of the
Department of Defense (DoD) is studying airflow in the lungs using computational fluid
dynamics in order to characterize disease-specific airflow patterns and provide useful
information for medical applications. To validate these models, they are seeking to obtain
experimental data of airflow in human lungs, both healthy and diseased. An assessment of
airflow can be obtained by using hyperpolarized noble gas (HNG) magnetic resonance imaging
(MRI) or, more specifically, hyperpolarized helium-3 (HHe) MRI in conjunction with
flow-encoding schemes that are well-established in conventional proton MRI

Four chronic obstructive pulmonary disease (COPD) patients and four healthy subjects will
undergo pulmonary function tests (PFTs), computed tomography (CT) scan covering the mouth,
neck, and chest, and hyperpolarized helium 3 MRI. Before and after the MRI scans, three
spirometry readings will be taken while the subject is lying in the same position as in the
MR scanners. Data will be analyzed by the BHSAI. UVa will provide the de-identified raw image
data and the de-identified results of the spirometry and other tests to BHSAI

Inclusion Criteria:

- Healthy subjects:

- Normal PFT values: FEV1 > 90% predicted; and Forced vital capacity (FVC) > 90%
predicted

- Normal chest x-ray (CXR)

- Medical history: No active pulmonary symptoms (cough, shortness of breath,
sputum); Negative history of pulmonary disease; Negative smoking history (never
smoked)

- Pulmonary Disease Subjects:

- PFT values: FEV1/FVC < 70% (indicative of obstruction); and 30% < FEV1 < 50%
predicted

- CXR normal except hyperinflation

- Symptoms - chronic shortness of breath

- All test subjects, healthy and with COPD should have similar physical anthropometric
characteristics:

- Similar age with age difference less than 3 years

- Similar height (within 3-4 inches)

Exclusion Criteria:

- Any condition for which a MRI procedure is contraindicated.

- Presence of any non-MRI compatible metallic material in the body, such as pacemakers,
metallic clips, etc.

- Likelihood of claustrophobia

- Chest circumference greater than that of the helium MR coil.

- Pregnancy, by report of subject. Clinically in the Department of radiology at UVA,
self report is used when screening patients for MR scans as well as CT scans and
fluoroscopy studies. If the subject reports there is any chance of their being
pregnant a urine pregnancy test will be performed prior to any imaging.
We found this trial at
1
site
1215 Lee St
Charlottesville, Virginia 22903
(434) 924-0211
Principal Investigator: Mike Shim, MD
Phone: 434-243-6074
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials